Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Shelby Barnett

Newcastle AuthorsTitleYearFull text
Dr Shelby Barnett
Dr Vickyanne Carruthers
Professor Deborah Tweddle
Professor Gareth Veal
Clinical pharmacology of cytotoxic drugs in neonates and infants: providing evidence-based dosing guidance2021
Dr Shelby Barnett
Professor Gareth Veal
Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom2021
Dr Shelby Barnett
PBPK Model of Coproporphyrin I: Evaluation of the Impact of SLCO1B1 Genotype, Ethnicity, and Sex on its Inter‐Individual Variability2021
Dr Shelby Barnett
Julie Errington
Julieann Sludden
Dr David Jamieson
Professor Gareth Veal
et al.
Pharmacokinetics and pharmacogenetics of cyclophosphamide in a neonate and infant childhood cancer patient population2021
Dr Shelby Barnett
Professor Deborah Tweddle
Professor Gareth Veal
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients2021
Dr Shelby Barnett
Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I2019
Dr Shelby Barnett
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B‐Mediated Drug–Drug Interactions Using Population Pharmacokinetic Modeling and Simulation2018
Dr Shelby Barnett
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems2016
Dr Shelby Barnett
Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues2015